Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pascal Biosciences Inc.

www.pascalbiosciences.com

Latest From Pascal Biosciences Inc.

Asia Deal Watch: Ambrx, NovoCodex Partner On Second ADC Candidate, For CD70-Positive Cancers

Deal follows 2013 pact between Ambrx and NovoCodex parent Zhejiang Medicine for HER2-positive-directed ADC. Astellas teams with Pandion on pancreatic cancer and Takeda with MD Anderson on CAR NK therapies.

Deals Business Strategies

Tech Transfer Roundup: Tmunity Targets Pediatric Glioma With UCSF-Discovered TCR Therapy

Bayer will collaborate with start-up Hope Medicine to develop antibody therapies targeting the PRL receptor. WARF and Sanford Burnham Prebys partner on translational research.

Research & Development Deals

Tech Transfer Roundup: J&J Houses JPOD Incubator At University Of Pennsylvania

Pascal and Oblato separately license therapeutic candidates for glioblastoma multiforme, while Cabaletta emerges from UPenn with novel program for CAAR-T therapies in B-cell mediated autoimmune disease.

Commercial Deals

Tech Transfer Roundup: Neon Licenses NKI IP To Advance Cell Therapy Into Clinic

Continuing a partnership between Neon co-founder and two Netherlands Cancer Institute researchers, agreement will help autologous T-cell candidate move into Phase I. Plus Scrip's monthly roundup of tech transfer deals.

Deals StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Alias(es)
  • bioMmune Technologies Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pascal Biosciences Inc.
  • Senior Management
  • Patrick W Gray, PhD, Pres. & CEO
    Judi Dalling, CFO
    Kevin Egan, VP, Bus. Dev.
    Larry Tjoelker, VP, Research
  • Contact Info
  • Pascal Biosciences Inc.
    Phone: (206) 221-7041
    Fluke Hall, Ste. 300
    4000 Mason Rd.
    P.O. Box 352141 Seattle, WA 98195
    USA
UsernamePublicRestriction

Register